Dana-Farber Researchers Unveil Promising Phase 2 Results for Targeted Therapy in Rare Bile Duct Cancer
Cholangiocarcinoma, a rare but aggressive malignancy originating in the bile ducts, has long posed a therapeutic challenge due to its...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
Cholangiocarcinoma, a rare but aggressive malignancy originating in the bile ducts, has long posed a therapeutic challenge due to its...
Jill P. Mesirov, PhD, a luminary in the worlds of mathematics and computational biology, has embarked on a new chapter...
A groundbreaking advancement in cancer immunotherapy has emerged from collaborative research led by scientists at University College London (UCL) and...
Dobutamine, a drug classically utilized for its cardiovascular benefits in managing acute heart failure, has recently captured the scientific community’s...
In recent years, the concept of “junk DNA” has undergone a dramatic transformation in the field of cancer biology, shifting...
In a groundbreaking advancement for colorectal cancer therapy, a collaborative team from the German Cancer Research Center (DKFZ) and the...
In a significant leap for the oncology research community, Gustave Roussy, Europe’s preeminent comprehensive cancer center, has joined forces with...
Arcus Biosciences, a clinical-stage global biopharmaceutical company, has unveiled groundbreaking data from the ARC-20 study evaluating casdatifan, an investigational small-molecule...
In a groundbreaking study published in the journal Cell Death Discovery, a team of researchers led by J. Fellenberg, S....
In a groundbreaking study published in the British Journal of Cancer, researchers have unveiled critical insights into cancer-related mortality following...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine